Journal of Assisted Reproduction and Genetics

, Volume 27, Issue 2, pp 69–74

Oocyte cryopreservation: is it time to remove its experimental label?

FERTILITY PRESERVATION

DOI: 10.1007/s10815-009-9382-y

Cite this article as:
Noyes, N., Boldt, J. & Nagy, Z.P. J Assist Reprod Genet (2010) 27: 69. doi:10.1007/s10815-009-9382-y

Abstract

As more reproductive-age women survive cancer at the expense of gonadotoxic therapy, the need for viable fertility preservation options has become paramount. Embryo cryopreservation, often using donor sperm, has been the standard offered these women over the past 20 years. Preservation of unfertilized oocytes now represents an acceptable and often equally viable alternative, particularly for single women, due to technologic advances made in the past decade. Given such, oocyte cryopreservation’s experimental designation and need for IRB approval should thus be revisited.

Keywords

Oocyte cryopreservationFertility preservationCancerSurvivalExperimental

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Nicole Noyes
    • 1
  • Jeffrey Boldt
    • 2
  • Zsolt Peter Nagy
    • 3
  1. 1.NYU Fertility CenterNYU School of MedicineNew YorkUSA
  2. 2.Assisted Fertility ServicesCommunity Health Network, Inc.IndianapolisUSA
  3. 3.Reproductive Biology AssociatesAtlantaUSA